Opioid manufacturer Insys files for bankruptcy after $225m settlement
pharmaceutical
Johnson & Johnson Opioid Trial To Begin In Oklahoma, Could Set Precedent : NPR
Heard on All Things Considered
“All eyes will be on Oklahoma this week when the first case in a flood of litigation against an opioid drug manufacturer begins on Tuesday.”
Check the Exorbitant Price of Zolgensma and Other Orphan Drugs – Bloomberg
“The day, long anticipated, when America’s system of voluntary drug pricing could break down has now arrived. Novartis has announced it will charge $2.1 millionfor Zolgensma, a gene therapy for infants with lethal spinal muscular atrophy.”
THN 